11:12 AM EST, 11/21/2023 (MT Newswires) -- After briefly opening in positive territory, European equities traded in the US as American depositary receipts were trending slightly lower in Tuesday trading, as they declined 0.14% to 1,231.63 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by medical device maker EDAP TMS (EDAP) and biopharmaceutical company Calliditas Therapeutics (CALT), which rose 2% and 1.8%, respectively. They were followed by 3D printer companies voxeljet (VJET) and Materialise (MTLS), which were up 1.5% and 1.1%, respectively.
The decliners from continental Europe were led by biopharmaceutical company MorphoSys (MOR) and biotech firm Evaxion Biotech (EVAX), which fell 23% and 7.4%, respectively. They were followed by biopharmaceutical company Cellectis (CLLS) and hotel booking site trivago (TRVG), which dropped 6.8% and 3.6%, respectively.
From the UK and Ireland, the gainers were led by biopharmaceutical company TC Biopharm (TCBP) and pharmaceutical company Silence Therapeutics (SLN), which climbed 7.5% and 6.4%, respectively. They were followed by biopharmaceutical company Akari Therapeutics (AKTX) and construction materials supplier CRH (CRH), which increased 5.4% and 3.6%, respectively.
The decliners from the UK and Ireland were led by biopharmaceutical companies NuCana (NCNA) and Bicycle Therapeutics (BCYC), which lost 5.8% and 2.7%, respectively. They were followed by biotech firm Autolus Therapeutics (AUTL) and cruise line operator Carnival (CUK), which were down 2.5% and 2.3%, respectively.
Copyright © 2023 MT Newswires. All rights reserved. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.